Revelation Biosciences
REVB
7 hedge funds and large institutions have $1.05M invested in Revelation Biosciences in 2023 Q1 according to their latest regulatory filings, with 6 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
500% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 1
250% more funds holding
Funds holding: 2 → 7 (+5)
145% more capital invested
Capital invested by funds: $427K → $1.05M (+$621K)
0.02% more ownership
Funds ownership: 0% → 0.02% (+0.02%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$999K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
+$837K |
| 3 |
Walleye Capital
New York
|
+$810K |
| 4 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$513K |
| 5 |
ACM
Altium Capital Management
New York
|
+$162K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
-$20.9K |
| 2 |
R
Rebalance
Palo Alto,
California
|
-$16.3K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$7.49K |
| 4 |
MFA
Mayflower Financial Advisors
Boston,
Massachusetts
|
-$4.07K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2K |
REVB Hedge Fund Activity: Q1 2023 in Review
7 of the 6,278 institutional investors tracked by Wall St. Rank reported a position in Revelation Biosciences (REVB) for Q1 2023, worth a combined $1.05M — up 145% from $427K a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new REVB positions and 1 closed out — a net gain of 5 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Anson Funds Management, opening a new position worth an estimated $999K. The largest seller was State Street, exiting entirely with an estimated $20.9K sold.
- 7 institutional investors held Revelation Biosciences (REVB) as of Q1 2023, up from 2 in Q4 2022.
- Funds reported $1.05M of Revelation Biosciences stock for Q1 2023, up 145% quarter-over-quarter.
- 6 funds opened new Revelation Biosciences positions in Q1 2023 and 1 closed out, a net change of +5 holders.
- The largest Revelation Biosciences buyer in Q1 2023 was Anson Funds Management, an estimated $999K added.
- The largest Revelation Biosciences seller in Q1 2023 was State Street, an estimated $20.9K sold.
Based on aggregated 13F filings for Q1 2023.